149 related articles for article (PubMed ID: 15686885)
1. Studies towards the next generation of antidepressants. Part 4: derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor.
Evrard DA; Zhou P; Yi SY; Zhou D; Smith DL; Sullivan KM; Hornby GA; Schechter LE; Andree TH; Mewshaw RE
Bioorg Med Chem Lett; 2005 Feb; 15(4):911-4. PubMed ID: 15686885
[TBL] [Abstract][Full Text] [Related]
2. Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives.
Zhou D; Zhou P; Evrard DA; Meagher K; Webb M; Harrison BL; Huryn DM; Golembieski J; Hornby GA; Schechter LE; Smith DL; Andree TH; Mewshaw RE
Bioorg Med Chem; 2008 Jul; 16(14):6707-23. PubMed ID: 18571421
[TBL] [Abstract][Full Text] [Related]
3. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
[TBL] [Abstract][Full Text] [Related]
5. Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors.
Meagher KL; Mewshaw RE; Evrard DA; Zhou P; Smith DL; Scerni R; Spangler T; Abulhawa S; Shi X; Schechter LE; Andree TH
Bioorg Med Chem Lett; 2001 Jul; 11(14):1885-8. PubMed ID: 11459653
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
[TBL] [Abstract][Full Text] [Related]
7. Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2.
Hatzenbuhler NT; Baudy R; Evrard DA; Failli A; Harrison BL; Lenicek S; Mewshaw RE; Saab A; Shah U; Sze J; Zhang M; Zhou D; Chlenov M; Kagan M; Golembieski J; Hornby G; Lai M; Smith DL; Sullivan KM; Schechter LE; Andree TH
J Med Chem; 2008 Nov; 51(21):6980-7004. PubMed ID: 18834188
[TBL] [Abstract][Full Text] [Related]
8. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new 4-butyl-arylpiperazine-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives and evaluation for their 5-HT
Wróbel MZ; Chodkowski A; Marciniak M; Dawidowski M; Maksymiuk A; Siwek A; Nowak G; Turło J
Bioorg Chem; 2020 Apr; 97():103662. PubMed ID: 32086055
[TBL] [Abstract][Full Text] [Related]
10. Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines.
Mewshaw RE; Zhou D; Zhou P; Shi X; Hornby G; Spangler T; Scerni R; Smith D; Schechter LE; Andree TH
J Med Chem; 2004 Jul; 47(15):3823-42. PubMed ID: 15239661
[TBL] [Abstract][Full Text] [Related]
11. Dual NK(1) antagonists--serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives.
Ryckmans T; Berton O; Grimée R; Kogej T; Lamberty Y; Pasau P; Talaga P; Genicot C
Bioorg Med Chem Lett; 2002 Nov; 12(21):3195-8. PubMed ID: 12372532
[TBL] [Abstract][Full Text] [Related]
12. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
Mewshaw RE; Meagher KL; Zhou P; Zhou D; Shi X; Scerni R; Smith D; Schechter LE; Andree TH
Bioorg Med Chem Lett; 2002 Feb; 12(3):307-10. PubMed ID: 11814784
[TBL] [Abstract][Full Text] [Related]
13. Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
Zhou D; Harrison BL; Shah U; Andree TH; Hornby GA; Scerni R; Schechter LE; Smith DL; Sullivan KM; Mewshaw RE
Bioorg Med Chem Lett; 2006 Mar; 16(5):1338-41. PubMed ID: 16332439
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT
Gu ZS; Zhou AN; Xiao Y; Zhang QW; Li JQ
Eur J Med Chem; 2018 Jan; 144():701-715. PubMed ID: 29291438
[TBL] [Abstract][Full Text] [Related]
15. Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.
Kang SY; Park EJ; Park WK; Kim HJ; Jeong D; Jung ME; Song KS; Lee SH; Seo HJ; Kim MJ; Lee M; Han HK; Son EJ; Pae AN; Kim J; Lee J
Bioorg Med Chem Lett; 2010 Mar; 20(5):1705-11. PubMed ID: 20149649
[TBL] [Abstract][Full Text] [Related]
16. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
Martínez J; Pérez S; Oficialdegui AM; Heras B; Orús L; Villanueva H; Palop JA; Roca J; Mourelle M; Bosch A; Del Castillo JC; Lasheras B; Tordera R; del Río J; Monge A
Eur J Med Chem; 2001 Jan; 36(1):55-61. PubMed ID: 11231049
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT(1A) receptor and the serotonin transporter.
Shen Z; Siva Ramamoorthy P; Hatzenbuhler NT; Evrard DA; Childers W; Harrison BL; Chlenov M; Hornby G; Smith DL; Sullivan KM; Schechter LE; Andree TH
Bioorg Med Chem Lett; 2010 Jan; 20(1):222-7. PubMed ID: 19932965
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
Bang-Andersen B; Ruhland T; Jørgensen M; Smith G; Frederiksen K; Jensen KG; Zhong H; Nielsen SM; Hogg S; Mørk A; Stensbøl TB
J Med Chem; 2011 May; 54(9):3206-21. PubMed ID: 21486038
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT
Wróbel MZ; Chodkowski A; Dawidowski M; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Satała G; Bojarski AJ; Turło J
Bioorg Chem; 2023 Dec; 141():106903. PubMed ID: 37827015
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
